Sawai Man Singh Medical College, also known as SMS Medical College, is a government medical college in Jaipur, Rajasthan state, India. It was established in 1947 and was the 15th centre for medical education in India.

During the past decade, SMS Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SMS Hospital" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Allergan" with 3 trials sponsored, "Merck KGaA, Darmstadt, Germany" with 3 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Peregrine Pharmaceuticals" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SMS Hospital" #1 collaborator was "Merck Ltd., India" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "SMS Hospital" are "Diabetes Mellitus" (3 trials), "Gastroparesis" (3 trials), "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Acute Bacterial Skin and Skin Structure Infections" (1 trials). Many other conditions were trialed in "SMS Hospital" in a lesser frequency.

Most popular intervention types in "SMS Hospital" are "Drug" (26 trials), "Biological" (3 trials), "Combination Product" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Filgotinib" (3 trials), "Relamorelin" (3 trials), "Cetuximab" (2 trials) and "Rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "SMS Hospital" are 30 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "SMS Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in SMS Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in SMS Hospital, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

SMS Hospital has several departments that took part in Clinical trials: "Acharya Tulsi Regional Cancer Treatment Research Institute" - 2 trials, "Birla Cancer Centre" - 2 trials